Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Director departure

Odonate Therapeutics, Inc. (ODT) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2022 SC 13G/A Ikarian Capital, LLC reports a 3.5% stake in Odonate Therapeutics, Inc.
02/10/2022 SC 13G/A JANUS HENDERSON GROUP PLC reports a 0% stake in Odonate Therapeutics, Inc.
02/07/2022 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
01/31/2022 EFFECT Form EFFECT - Notice of Effectiveness:
01/31/2022 EFFECT Form EFFECT - Notice of Effectiveness:
01/31/2022 EFFECT Form EFFECT - Notice of Effectiveness:
01/28/2022 SC 13G/A BML Investment Partners, L.P. reports a 7.4% stake in Odonate Therapeutics Inc
01/28/2022 SC 13G BML Investment Partners, L.P. reports a 7.4% stake in Odonate Therapeutics Inc
01/26/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/26/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
01/26/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/26/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
01/26/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
01/25/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
01/07/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
12/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/26/2021 SC 13D/A Boxer Capital, LLC reports a 10.9% stake in Odonate Therapeutics, Inc.
11/24/2021 4 Boxer Capital, LLC (10% Owner) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Sold 200,000 shares @ $1.5483, valued at $309.7k
Sold 200,000 shares @ $1.5684, valued at $313.7k
11/22/2021 SC 13D/A Boxer Capital, LLC reports a 12% stake in Odonate Therapeutics, Inc.
11/19/2021 4 Davis Aaron I. (10% Owner) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Sold 170,000 shares @ $2.2334, valued at $379.7k
Sold 600,000 shares @ $2.1654, valued at $1.3M
Sold 250,000 shares @ $1.949, valued at $487.3k
Sold 30,000 shares @ $1.9165, valued at $57.5k
Sold 150,000 shares @ $1.8419, valued at $276.3k
11/19/2021 4 Boxer Capital, LLC (10% Owner) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Sold 600,000 shares @ $2.1654, valued at $1.3M
Sold 250,000 shares @ $1.949, valued at $487.3k
Sold 150,000 shares @ $1.8419, valued at $276.3k
11/19/2021 SC 13D/A TANG CAPITAL PARTNERS LP reports a 33.7% stake in Odonate Therapeutics, Inc.
11/19/2021 4 TANG KEVIN C (CEO) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Sold 468,849 shares @ $2.6583, valued at $1.2M
Sold 31,151 shares @ $1.9941, valued at $62.1k
Sold 500,000 shares @ $2.0161, valued at $1M
Sold 287,577 shares @ $2.1985, valued at $632.2k
Sold 212,423 shares @ $1.9708, valued at $418.6k
Sold 500,000 shares @ $1.8812, valued at $940.6k
Sold 381,842 shares @ $1.8925, valued at $722.6k
Sold 365,289 shares @ $1.9161, valued at $699.9k
11/18/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Odonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase Plan"
11/18/2021 SC 13G/A EcoR1 Capital, LLC reports a 14.8% stake in Odonate Therapeutics, Inc.
11/18/2021 3 EcoR1 Capital, LLC (10% Owner) has filed a Form 3 on Odonate Therapeutics, Inc.
11/10/2021 10-Q Quarterly Report for the period ended September 30, 2021
08/05/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/27/2021 10-Q Quarterly Report for the period ended June 30, 2021
07/19/2021 SC 13G EcoR1 Capital, LLC reports a 8.7% stake in Odonate Therapeutics, Inc.
07/02/2021 SC 13G Ikarian Capital, LLC reports a 5.2% stake in Odonate Therapeutics, Inc.
06/25/2021 8-K Quarterly results
06/01/2021 DEF 14A Form DEF 14A - Other definitive proxy statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy